MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
RLMD Relmada Therapeutics
- 0.363
- +0.010+2.89%
Close Dec 20 16:00 ET
- 0.372
- +0.009+2.56%
Post 20:01 ET
10.95MMarket Cap-0.13P/E (TTM)
0.380High0.343Low425.05KVolume0.343Open0.353Pre Close154.56KTurnover1.54%Turnover RatioLossP/E (Static)30.17MShares7.22352wk High0.23P/B9.99MFloat Cap0.34252wk Low--Dividend TTM27.54MShs Float54.000Historical High--Div YieldTTM10.49%Amplitude0.342Historical Low0.363Avg Price1Lot Size
About Relmada Therapeutics Company
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Company Profile
SymbolRLMD
Company NameRelmada Therapeutics
Listing DateOct 10, 2019
Issue Price0.00
Founded2012
CEODr. Sergio Traversa
MarketNASDAQ
Employees20
Fiscal Year Ends12-31
Address2222 Ponce de Leon Boulevard,3rd floor
CityCoral Gables
ProvinceFlorida
CountryUnited States of America
Zip Code33134
Phone1-786-629-1376
Websitehttp://www.relmada.com
Company Executives
- Name
- Position
- Salary
- Dr. Sergio Traversa
- Chief Executive Officer and Director
- 4.78M
- Maged Shenouda
- Chief Financial Officer and Principal Accounting Officer
- 2.34M
- Charles S. Ence
- Chief Accounting and Compliance Officer
- 2.33M
- Charles J. Casamento
- Chairman of the Board
- 674.90K
- Fabiana Fedeli
- Independent Director
- 1.33M
- Paul Kelly
- Independent Director
- 1.67M
- John Glasspool
- Independent Director
- 604.77K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.